site background
Skip to content
Ivy Brain Tumor Center
Trial EligibilityDonate
Main Menu
  • Physicians
  • Industry
  • Ivy Blog
Talk to an Ivy Navigator
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Clinical Trials
    • Current Trials
      • SONODYNAMIC THERAPY IN RECURRENT GLIOBLASTOMA
      • AZD1390 For Recurrent Grade IV Glioma
      • Sonodynamic Therapy in Recurrent High-Grade Glioma
      • Niraparib for Newly Diagnosed Glioblastoma
      • Pamiparib for newly diagnosed or recurrent glioblastoma
      • Abemaciclib Plus LY3214996 For Recurrent Glioblastoma
      • Sonodynamic Therapy in DIPG
      • Infigratinib in Recurrent Glioblastoma Patients
      • RIBOCICLIB FOR RECURRENT GLIOBLASTOMA
      • RIBOCICLIB FOR RECURRENT MENINGIOMA
    • What is a Phase 0 Trial?
    • Why Ivy Clinical Trials?
    • What We Treat
      • Gliomas
      • Brain Metastases
      • Meningiomas
      • Ependymomas
      • Craniopharyngiomas
      • Pineal-Region Tumors
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
      • Lodging
      • Transportation
    • Patient Support
    • FAQs
    • Share Your Story
  • Research
    • Scientific Cores
    • Laboratories
      • Mehta Laboratory
      • Tovmasyan Laboratory
      • Tien Laboratory
      • Mirzadeh Laboratory
    • Certifications
    • Preclinical Work
    • Industry Collaboration
    • Published Research
    • Ivy Center Seminar Series
  • About
    • Team
      • Administration
      • Business Operations
      • Clinical Operations
      • Communications
      • Preclinical and Translational Science
      • Clinicians
    • New Ivy Headquarters
    • It’s personal
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us
  • ESPAÑOL

Talk to an Ivy Navigator

602-406-8605
Home » About » Team » Nader Sanai, MD
Headshot of Nader Sanai
  • phone:(602) 406-3135
  • Send Email

Nader Sanai, MD

Chief Scientific Officer/Director Neurosurgical Oncologist

Dr. Nader Sanai is an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors. As a practicing neurosurgeon, his specialty clinical practice is devoted entirely to patients with tumors of the brain and spine, including those in high-risk areas. He also has extensive experience using intraoperative mapping techniques to maximize tumor removal while preserving crucial structures controlling motor and language function. Gliomas, meningiomas, metastatic tumors, and complex tumors of the skull base are just some of the tumor types he routinely treats using both operative and radiosurgery techniques. As the Southwest’s busiest neurosurgical oncologist, with over 3000 brain tumor surgeries performed since 2010, Dr. Sanai has one of the largest experiences in the world. Among various career accolades, Dr. Sanai was recently elected to the American Academy of Neurological Surgeons, the most respected academic organization in neurosurgery.

To date, Dr. Sanai has published over 200 peer-reviewed research manuscripts and delivered over 200 national and international lectures on brain tumor research. Collectively, Dr. Sanai’s published research has led to over 15,000 total citations and an H-index of 45 – one of the highest for an academic neurosurgeon in the United States. As the Director of the Ivy Brain Tumor Center, Dr. Sanai oversees all translational brain tumor research at the Barrow Neurological Institute, located within the Dignity Health St. Joseph’s Hospital & Medical Center in Phoenix, Arizona. At the Ivy Center, Dr. Sanai serves as the Principal Investigator of the Laboratory for Stem Cell Neuro-Oncology, which is funded by over a dozen external granting agencies, including the National Institutes of Health (NIH). Dr. Sanai is one of only a handful of neurosurgeons in the United States serving to have served as principal investigator of multiple NIH R01 grants.

Dr. Sanai is the principal architect of the Ivy Center’s highly-innovative and world-renowned Phase 0 clinical trials program. Together with a multidisciplinary team of scientists, clinicians, and nurses, Dr. Sanai specializes in identifying new, first-in-class therapeutic agents that match the individual biologies of brain tumor patients. The Ivy Center’s precision medicine program is the first of its kind in neuro-oncology and reflects Dr. Sanai’s commitment to pushing the envelope for brain tumor patients around the world.

Click here to learn more about Dr. Sanai and why the fight against brain cancer is personal to him.

Arial shot of the Ivy Brain Tumor Center
Ivy Brain Tumor Center
  • The Challenge
    • Current Standard of Care
    • Conventional Clinical Trials
  • Phase 0 Clinical Trials
    • Why Ivy Clinical Trials?
    • What We Treat
    • Brain Tumor Clinical Trials
  • Patients
    • Patient Stories
    • What to Expect
    • Planning Your Visit
    • Patient Support
    • FAQs
  • About
    • Team
    • Barrow Neurological Institute
    • The Ben and Catherine Ivy Foundation
    • Newsroom
    • Events
    • Donate
    • Careers
    • Contact Us

Stay Updated

Follow Us

  • Facebook
  • Twitter
  • Instagram
  • LinkedIn
  • YouTube

2910 North Third Avenue
Phoenix, Arizona 85013
(602) 406-6489
[email protected]
Mailing Address for Donations »

© Ivy Brain Tumor Center, 2023. All Rights Reserved.
  • Privacy Policy
  • Site Map
Important Notice

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device.